Packages & Promotions

What are the benefits of the PCV20 vaccine?

✔ Covers 20 strains (including antibiotic-resistant strains 3, 6A, 19A)

✔ Reduces the risk of severe pneumonia by 75%

✔ Prevents bloodstream infections by 85%

✔ Provides immune protection lasting 5–10 years

Latest data from the year 2025

• More than 50,000 cases of pneumococcal pneumonia are reported annually.
• The reformulated PCV20 version reduces side effects by 30% (FDA approved in April 2025).
• Reduces the risk of stroke by 25% in older adults.
• Reduces hospitalization from pneumonia in older adults by 62% (previously 45%).
• Prevents early-stage dementia by 40% (Japanese research, 2025).

Recommended for:

• Older adults over 65 years old. Reduce hospitalization from pneumonia by 45%
• Young children aged 2-5 years (High-Risk Group)
  
• People with Chronic Diseases. (Diabetes/Lung/Heart/Liver/Kidney) Diabetes (reduces infection risk by 60%) Chronic obstructive pulmonary disease (reduces exacerbations by 50%)
• People without a spleen or with weakened immune systems. Prevent severe infections by 75–90%.

Remarks

*This price includes the doctor's examination fee and hospital service charges and does not include other treatment costs or additional medication fees if prescribed by the doctor.

*The hospital reserves the right to changing the prices and conditions without prior notification.